PD-029Regorafenib dose escalations in the prospective, observational CORRELATE study in patients with metastatic colorectal cancer. (2nd July 2019) - Ducreux, M; O'Connor, J; Dochy, E; Fiala-Buskies, S; Cervantes, A; Falcone, A; ,